Țară: Singapore
Limbă: engleză
Sursă: HSA (Health Sciences Authority)
Vernakalant 18.1mg/ml equivalent Vernakalant hydrochloride
ZUELLIG PHARMA PTE. LTD.
C01BG11
20mg/ml
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Prescription Only
hameln pharmaceuticals GmbH
2012-09-13
BRINAVESS SG-MK6621-IV-032012 (Vernakalant, MSD) 1 LOCAL PRODUCT CIRCULAR CONCENTRATE FOR SOLUTION FOR INFUSION BRINAVESS (VERNAKALANT, MSD) _ _ I. THERAPEUTIC CLASS BRINAVESS * is an antiarrhythmic drug with relative atrial selectivity. BRINAVESS is supplied as Concentrate for Solution for Infusion (sterile concentrate). It is a clear and colorless to pale yellow solution with a pH of approximately 5.5. The molecule is a synthetic enantiomerically pure new chemical entity and is chemically described as 3-Pyrrolidinol, 1-[(1_R_,2_R_)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, hydrochloride, (3_R_)- [ or alternately as (1_R_,2_R_)-2-[(3_R_)-hydroxypyrrolidinyl]-1-(3,4- dimethoxyphenethoxy)cyclohexane monohydrochloride ] Its empirical formula is C 20 H 31 NO 4 ·HCl and its structural formula is shown below . Vernakalant hydrochloride is a crystalline, white to beige powder with a relative molecular mass of 385.93 g/mol. It is soluble (276 – 496 mg/mL) in aqueous solutions throughout the pH range of 1.0 to 13.0. III. COMPOSITION _ _ _IIIA. ACTIVE INGREDIENTS_ Each ml of concentrate contains 20 mg of vernakalant hydrochloride which is equivalent to 18.1 mg of vernakalant free base. _IIIB. INACTIVE INGREDIENTS_ Citric acid E330 Sodium chloride Water for injection Copyright © 2009 MERCK & CO., INC. II. CHEMISTRY O OMe OMe HCl N OH _R_ _R_ _R_ BRINAVESS SG-MK6621-IV-032012 (Vernakalant, MSD) 2 Sodium hydroxide E524 (for pH-adjustment) IV. CLINICAL PHARMACOLOGY _IVA. MECHANISM OF ACTION _ Mechanism of Action: Vernakalant is an antiarrhythmic medicine that acts preferentially in Citiți documentul complet